85 related articles for article (PubMed ID: 19695794)
1. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.
Mizumoto M; Yamamoto T; Ishikawa E; Matsuda M; Takano S; Ishikawa H; Okumura T; Sakurai H; Matsumura A; Tsuboi K
J Neurooncol; 2016 Oct; 130(1):165-170. PubMed ID: 27535747
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.
Mizumoto M; Yamamoto T; Takano S; Ishikawa E; Matsumura A; Ishikawa H; Okumura T; Sakurai H; Miyatake S; Tsuboi K
Pract Radiat Oncol; 2015; 5(1):e9-16. PubMed ID: 25413424
[TBL] [Abstract][Full Text] [Related]
4. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
[TBL] [Abstract][Full Text] [Related]
6. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
7. [Clinical prognostic factors of adult supratentorial glioblastoma].
Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
[No Abstract] [Full Text] [Related]
8. Satisfactory therapy results of combining nimustine with nicardipine against glioma at advanced stage.
Lou M; Zhao Y
J Cancer Res Ther; 2015; 11(4):1030. PubMed ID: 26881613
[TBL] [Abstract][Full Text] [Related]
9. INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study.
Giordano FA; Brehmer S; Abo-Madyan Y; Welzel G; Sperk E; Keller A; Schneider F; Clausen S; Herskind C; Schmiedek P; Wenz F
BMC Cancer; 2014 Dec; 14():992. PubMed ID: 25535398
[TBL] [Abstract][Full Text] [Related]
10. Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients.
Lim WH; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
PLoS One; 2018; 13(2):e0192838. PubMed ID: 29444157
[TBL] [Abstract][Full Text] [Related]
11. Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
Yu VY; Nguyen D; O'Connor D; Ruan D; Kaprealian T; Chin R; Sheng K
PLoS One; 2021; 16(2):e0245676. PubMed ID: 33524046
[TBL] [Abstract][Full Text] [Related]
12. The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy.
Zheng L; Zhou ZR; Yu Q; Shi M; Yang Y; Zhou X; Li C; Wei Q
Front Oncol; 2020; 10():615368. PubMed ID: 33692942
[TBL] [Abstract][Full Text] [Related]
13. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
Mu L; Wang Y; Wang Y; Zhang H; Shang D; Tan F; Li Y; Chen X
World Neurosurg; 2017 Jan; 97():279-283. PubMed ID: 27744078
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost.
Liang HT; Mizumoto M; Ishikawa E; Matsuda M; Tanaka K; Kohzuki H; Numajiri H; Oshiro Y; Okumura T; Matsumura A; Sakurai H
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3503-3516. PubMed ID: 34459971
[TBL] [Abstract][Full Text] [Related]
15. Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma.
Ghosh S; Baker S; de Castro DG; Kepka L; Kumar N; Sinaika V; Matiello J; Lomidze D; Dyttus-Cebulok K; Rosenblatt E; Fidarova E; Roa W
Radiother Oncol; 2018 Apr; 127(1):114-120. PubMed ID: 29452901
[TBL] [Abstract][Full Text] [Related]
16. A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma.
Matsuyama T; Fukugawa Y; Kuroda J; Toya R; Watakabe T; Matsumoto T; Oya N
Radiat Oncol; 2022 Feb; 17(1):40. PubMed ID: 35193635
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Glioblastoma Multiforme (grade IV - WHO 2007): a case of complete objective response - concomitant administration of Somatostatin / Octreotide, Retinoids, Vit E, Vit D3, Vit C, Melatonin, D2 R agonists (Di Bella Method.
Di Bella G; Leci J; Ricchi A; Toscano R
Neuro Endocrinol Lett; 2015; 36(2):127-32. PubMed ID: 26071580
[TBL] [Abstract][Full Text] [Related]
18. A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.
Wick W; Fricke H; Junge K; Kobyakov G; Martens T; Heese O; Wiestler B; Schliesser MG; von Deimling A; Pichler J; Vetlova E; Harting I; Debus J; Hartmann C; Kunz C; Platten M; Bendszus M; Combs SE
Clin Cancer Res; 2014 Dec; 20(24):6304-13. PubMed ID: 25338498
[TBL] [Abstract][Full Text] [Related]
19. A new approach to delineating clinical target volume for radiotherapy of glioblastoma: A phase II trial.
Huang Y; Ding H; Luo M; Li Z; Li S; Xie C; Zhong Y
Front Oncol; 2022; 12():931436. PubMed ID: 36338715
[TBL] [Abstract][Full Text] [Related]
20. GBM surgery in the elderly-time to be more aggressive?
Badhiwala JH; Nassiri F; Almenawer SA
Clin Neurol Neurosurg; 2016 Feb; 141():131-2. PubMed ID: 26521109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
